María Teresa Gómez‐Casares

Author

Hospital Universitario de Gran Canaria Doctor Negrín ORCID

Also Known As

Carmen García-Hernández, Francisca Ferrer-Marín, GOMEZ CASARES, MARIA TERESA, Gómez Casares, María Teresa, M T Gomez, M T Gomez-Casares, M T Gómez Casares, M T Gómez-Casares, M Teresa Gómez Casares, M Teresa Gómez-Casares

252

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario de Gran Canaria Doctor Negrín Hospital Universitario 12 De Octubre Hospital Universitario Ramón y Cajal Hospital Del Mar Hospital Clínico Universitario de Valencia

About

María Teresa Gómez‐Casares is an author at Hospital Universitario de Gran Canaria Doctor Negrín specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.2K
2	Health Sciences	7	7	372
3	Cell Biology	6	6	197
4	Public Health	3	3	163
5	Biostatistics	2	2	48

María Teresa Gómez‐Casares

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study Andreas Hochhaus, Tamás Masszi, Francis J. Giles, Leukemia	2017	286
Interactions between Tumor Necrosis Factor-α, Hypothalamic Corticotropin-Releasing Hormone, and Adrenocorticotropin Secretion in the Rat* Renato Bernardini, Themis C. Kamilaris, Aldo E. Calogero, Endocrinology Hypothalamic Corticotropin-releasing HormoneImmunologyImmune RegulationCell DeathGlucocorticoid	1990	232
Clinical and therapeutic features of myasthenia gravis in adults based on age at onset Elena Cortés‐Vicente, Rodrigo Álvarez‐Velasco, Sonia Segovia, Neurology	2020	159
Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study Neil P. Shah, Valentín García‐Gutiérrez, Antonio Jiménez‐Velasco, Leukemia & lymphoma/Leukemia and lymphoma	2019	146
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation Alberto Álvarez‐Larrán, Arturo Pereira, Paola Guglielmelli, Haematologica	2016	145
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study David M. Ross, Tamás Masszi, María Teresa Gómez‐Casares, Journal of Cancer Research and Clinical Oncology	2018	140
Occupational Exposure to Hepatitis E Virus (HEV) in Swine Workers Carolina Galiana, Salceda Fernández-Barredo, María Teresa Gómez‐Casares, American Journal of Tropical Medicine and Hygiene Occupational HazardsOccupational ExposureEnvironmental HealthGastrointestinal VirusOccupational Medicine	2008	119
Acquired von willebrand disease in multiple myeloma secondary to absorption of von willebrand factor by plasma cells Carlos Richard, M A Cuadrado, Marta Prieto, American Journal of Hematology	1990	104
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes Rafael Díaz de la Guardia, Belén López‐Millán, Jessie R. Lavoie, Stem Cell Reports Cell TherapyDevelopmental BiologyDetailed CharacterizationMedicineHematology	2017	97
Detection of Hepatitis E Virus Shedding in Feces of Pigs at Different Stages of Production Using Reverse Transcription-Polymerase Chain Reaction Salceda Fernández-Barredo, Carolina Galiana, Santiago Vega, Journal of Veterinary Diagnostic Investigation	2006	96

Page 1